{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T07:16:33Z","timestamp":1792653393353,"version":"4.5.0"},"reference-count":62,"publisher":"Cambridge University Press (CUP)","issue":"14","license":[{"start":{"date-parts":[[2017,4,20]],"date-time":"2017-04-20T00:00:00Z","timestamp":1492646400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/www.cambridge.org\/core\/terms"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Psychol. Med."],"published-print":{"date-parts":[[2017,10]]},"abstract":"<jats:sec id=\"S0033291717000976_sec_a1\"><jats:title>Background<\/jats:title><jats:p>Many studies have concluded that cannabis use disorder (CUD) negatively influences outcomes in first-episode psychosis (FEP). However, few have taken into account the impact of concurrent misuse of other substances.<\/jats:p><\/jats:sec><jats:sec id=\"S0033291717000976_sec_a2\" sec-type=\"methods\"><jats:title>Methods<\/jats:title><jats:p>This 2-year, prospective, longitudinal study of FEP patients, aged between 18 and 30 years, admitted to early intervention programs in Montreal, Quebec, Canada, examined the specific influence of different substance use disorders (SUD) (alcohol, cannabis, cocaine, amphetamines) on service utilization, symptomatic and functional outcomes in FEP.<\/jats:p><\/jats:sec><jats:sec id=\"S0033291717000976_sec_a3\" sec-type=\"results\"><jats:title>Results<\/jats:title><jats:p>Drugs and alcohol were associated with lower functioning, but drugs had a greater negative impact on most measures at 2-year follow-up. Half of CUD patients and more than 65% of cocaine or amphetamine abusers presented polysubstance use disorder (poly-SUD). The only group that deteriorated from years 1 to 2 (symptoms and functioning) were patients with persistent CUD alone. Outcome was worse in CUD than in the no-SUD group at 2 years. Cocaine, amphetamines and poly-SUD were associated with worse symptomatic and functional outcomes from the 1st year of treatment, persisting over time with higher service utilization (hospitalization).<\/jats:p><\/jats:sec><jats:sec id=\"S0033291717000976_sec_a4\" sec-type=\"conclusion\"><jats:title>Conclusion<\/jats:title><jats:p>The negative impact attributed to CUD in previous studies could be partly attributed to methodological flaws, like including polysubstance abusers among cannabis misusers. However, our investigation confirmed the negative effect of CUD on outcome. Attention should be paid to persistent cannabis misusers, since their condition seems to worsen over time, and to cocaine and amphetamine misusers, in view of their poorer outcome early during follow-up and high service utilization.<\/jats:p><\/jats:sec>","DOI":"10.1017\/s0033291717000976","type":"journal-article","created":{"date-parts":[[2017,4,20]],"date-time":"2017-04-20T06:09:42Z","timestamp":1492668582000},"page":"2461-2471","source":"Crossref","is-referenced-by-count":45,"title":["Specific impact of stimulant, alcohol and cannabis use disorders on first-episode psychosis: 2-year functional and symptomatic outcomes"],"prefix":"10.1017","volume":"47","author":[{"given":"C.","family":"Ouellet-Plamondon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Abdel-Baki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c9.","family":"Salvat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Potvin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"56","published-online":{"date-parts":[[2017,4,20]]},"reference":[{"key":"S0033291717000976_ref29","doi-asserted-by":"publisher","DOI":"10.1093\/schbul\/13.2.261"},{"key":"S0033291717000976_ref4","volume-title":"Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision (DSM-IV-TR)","volume":"1","year":"2000"},{"key":"S0033291717000976_ref26","doi-asserted-by":"publisher","DOI":"10.1017\/S0033291707000797"},{"key":"S0033291717000976_ref46","doi-asserted-by":"publisher","DOI":"10.1111\/eip.12067"},{"key":"S0033291717000976_ref15","volume-title":"Outcomes Assessment in Clinical Practice","author":"Drake","year":"1996"},{"key":"S0033291717000976_ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.eurpsy.2004.09.013"},{"key":"S0033291717000976_ref25","doi-asserted-by":"publisher","DOI":"10.1016\/S0033-3182(95)71666-8"},{"key":"S0033291717000976_ref13","doi-asserted-by":"publisher","DOI":"10.1093\/schbul\/6.4.606"},{"key":"S0033291717000976_ref10","doi-asserted-by":"publisher","DOI":"10.1093\/schbul\/sbu095"},{"key":"S0033291717000976_ref37","doi-asserted-by":"publisher","DOI":"10.1017\/S0033291707002656"},{"key":"S0033291717000976_ref11","doi-asserted-by":"publisher","DOI":"10.1097\/00005053-199304000-00003"},{"key":"S0033291717000976_ref58","first-page":"892","article-title":"Patterns and predictors of substance use disorders and daily tobacco use in first-episode psychosis","volume":"39","author":"Wade","year":"2005","journal-title":"The Australian and New Zealand Journal of Psychiatry"},{"key":"S0033291717000976_ref60","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.bp.107.046375"},{"key":"S0033291717000976_ref62","doi-asserted-by":"publisher","DOI":"10.1002\/mds.23227"},{"key":"S0033291717000976_ref21","doi-asserted-by":"publisher","DOI":"10.1093\/schbul\/sbp126"},{"key":"S0033291717000976_ref54","doi-asserted-by":"publisher","DOI":"10.1016\/S0924-9338(03)00027-0"},{"key":"S0033291717000976_ref53","doi-asserted-by":"publisher","DOI":"10.1111\/eip.12163"},{"key":"S0033291717000976_ref47","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.154.12.1726"},{"key":"S0033291717000976_ref41","doi-asserted-by":"publisher","DOI":"10.7202\/016523ar"},{"key":"S0033291717000976_ref61","first-page":"407171","article-title":"Oral versus long-acting injectable antipsychotics in the treatment of schizophrenia and special populations at risk for treatment nonadherence: a systematic review","author":"Zhornitsky","year":"2012","journal-title":"Schizophrenia Research and Treatment"},{"key":"S0033291717000976_ref39","doi-asserted-by":"publisher","DOI":"10.1177\/0004867411433211"},{"key":"S0033291717000976_ref16","first-page":"87","article-title":"Alcohol-use disorder and severe mental illness","volume":"20","author":"Drake","year":"1996","journal-title":"Alcohol Research and Health"},{"key":"S0033291717000976_ref24","doi-asserted-by":"publisher","DOI":"10.2147\/PROM.S42735"},{"key":"S0033291717000976_ref33","doi-asserted-by":"publisher","DOI":"10.1177\/0004867414525838"},{"key":"S0033291717000976_ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2012.07.023"},{"key":"S0033291717000976_ref5","doi-asserted-by":"publisher","DOI":"10.1093\/schbul\/sbn137"},{"key":"S0033291717000976_ref12","doi-asserted-by":"publisher","DOI":"10.1097\/00005053-199109000-00001"},{"key":"S0033291717000976_ref2","doi-asserted-by":"publisher","DOI":"10.1016\/0920-9964(90)90005-R"},{"key":"S0033291717000976_ref30","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.2009.01385.x"},{"key":"S0033291717000976_ref34","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2006.07.018"},{"key":"S0033291717000976_ref14","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0447.2002.02437.x"},{"key":"S0033291717000976_ref3","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.2006.00900.x"},{"key":"S0033291717000976_ref6","doi-asserted-by":"publisher","DOI":"10.2174\/157340009788971074"},{"key":"S0033291717000976_ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.psychres.2016.11.007"},{"key":"S0033291717000976_ref48","doi-asserted-by":"publisher","DOI":"10.1177\/070674370605100808"},{"key":"S0033291717000976_ref51","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.schbul.a033386"},{"key":"S0033291717000976_ref27","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1176\/ajp.152.6.856","article-title":"Predicting the \u2018revolving door\u2019 phenomenon among patients with schizophrenic, schizoaffective, and affective disorders","volume":"152","author":"Haywood","year":"1995","journal-title":"The American Journal of Psychiatry"},{"key":"S0033291717000976_ref32","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.2005.00554.x"},{"key":"S0033291717000976_ref36","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1994.03950040017002"},{"key":"S0033291717000976_ref42","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2011.04.006"},{"key":"S0033291717000976_ref44","doi-asserted-by":"publisher","DOI":"10.7202\/1008589ar"},{"key":"S0033291717000976_ref20","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1176\/ajp.149.9.1148","article-title":"Revising axis V for DSM-IV: a review of measures of social functioning","volume":"149","author":"Goldman","year":"1992","journal-title":"American Journal of Psychiatry"},{"key":"S0033291717000976_ref59","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.bp.105.017236"},{"key":"S0033291717000976_ref31","doi-asserted-by":"publisher","DOI":"10.1093\/schbul\/sbp031"},{"key":"S0033291717000976_ref18","doi-asserted-by":"publisher","DOI":"10.2174\/1874473711104040228"},{"key":"S0033291717000976_ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpsychires.2007.09.002"},{"key":"S0033291717000976_ref38","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.2009.01483.x"},{"key":"S0033291717000976_ref45","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1176\/ps.47.8.853","article-title":"Medication noncompliance and substance abuse among patients with schizophrenia","volume":"47","author":"Owen","year":"1996","journal-title":"Psychiatric Services"},{"key":"S0033291717000976_ref56","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.bp.108.057471"},{"key":"S0033291717000976_ref57","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4088\/JCP.7090su1cj","article-title":"The expert consensus guideline series: adherence problems in patients with serious and persistent mental illness","volume":"70","author":"Velligan","year":"2009","journal-title":"The Journal of Clinical Psychiatry"},{"key":"S0033291717000976_ref19","doi-asserted-by":"publisher","DOI":"10.1177\/0269881114562092"},{"key":"S0033291717000976_ref28","doi-asserted-by":"publisher","DOI":"10.1093\/schbul\/10.3.388"},{"key":"S0033291717000976_ref43","volume-title":"Australian Clinical Guidelines for Early Psychosis","year":"2016"},{"key":"S0033291717000976_ref23","volume-title":"ECDEU Assessment Manual for Psychopharmacology","author":"Guy","year":"1976"},{"key":"S0033291717000976_ref35","doi-asserted-by":"publisher","DOI":"10.1177\/070674371205700204"},{"key":"S0033291717000976_ref50","doi-asserted-by":"publisher","DOI":"10.1016\/S2215-0366(15)00363-6"},{"key":"S0033291717000976_ref55","doi-asserted-by":"publisher","DOI":"10.1097\/01.nmd.0000202575.79453.6e"},{"key":"S0033291717000976_ref40","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.b.32177"},{"key":"S0033291717000976_ref7","doi-asserted-by":"publisher","DOI":"10.1093\/schbul\/sbm011"},{"key":"S0033291717000976_ref9","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.bp.106.024448"},{"key":"S0033291717000976_ref52","doi-asserted-by":"publisher","DOI":"10.1097\/00005053-199010000-00005"},{"key":"S0033291717000976_ref49","doi-asserted-by":"publisher","DOI":"10.1177\/0004867414561526"}],"container-title":["Psychological Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S0033291717000976","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,16]],"date-time":"2019-04-16T22:36:06Z","timestamp":1555454166000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S0033291717000976\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4,20]]},"references-count":62,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["S0033291717000976"],"URL":"https:\/\/doi.org\/10.1017\/s0033291717000976","relation":{},"ISSN":["0033-2917","1469-8978"],"issn-type":[{"value":"0033-2917","type":"print"},{"value":"1469-8978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,4,20]]}}}